TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
QUIA PHARMA AB (publ)
Closing information (x1000 EUR)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
0
|
0
|
21 |
| Financial expenses |
91
|
386
|
238 |
| Earnings before taxes |
-1,489
|
-1,805
|
-1,956 |
| EBITDA |
-1,050
|
-1,117
|
-1,503 |
| Total assets |
3,781
|
2,107
|
2,324 |
| Current assets |
159
|
338
|
615 |
| Current liabilities |
2,407
|
523
|
657 |
| Equity capital |
1,374
|
217
|
2 |
| - share capital |
2,100
|
2,129
|
4,173 |
| Employees (average) |
3
|
4
|
5 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
36.3%
|
10.3%
|
0.1% |
| Turnover per employee |
0
|
0
|
4 |
| Profit as a percentage of turnover | -9314.3% | ||
| Return on assets (ROA) |
-37.0%
|
-67.3%
|
-73.9% |
| Current ratio |
6.6%
|
64.6%
|
93.6% |
| Return on equity (ROE) |
-108.4%
|
-831.8%
|
-97800% |
| Change turnover |
0
|
-19
|
-161 |
| Change turnover % |
-100%
|
-88% | |
| Chg. No. of employees |
-1
|
-1
|
2 |
| Chg. No. of employees % |
-25%
|
-20%
|
67% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.